| Name | Title | Contact Details |
|---|
The APIsec security testing platform discovers the most serious API vulnerabilities that lead to data theft and compromise.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Finding the most valuable customers is difficult and it takes intelligent technology to understand the user purchasing habits. YouAppi focuses solely on customer acquisition for mobile app owners. YouAppi drives the acquisition and conversion of the most profitable mobile customers through our proprietary predictive algorithms and analysis of the usage habits of 1.1 billion mobile users. Our OneRun™ Platform delivers higher Customer Lifetime Value (LTV) and the ability to scale customer acquisition with greater insight and control over revenue. YouAppi`s global team is based in San Francisco,New York City, London, Berlin and Israel.
Deploy enterprise-ready PostgreSQL on your choice of platform and infrastructure with commercial support from Crunchy Data.
ERP solution & service experts. Mobile B2B apps solve wholesale distributor problems in delivery, inventory, & remote sales. Thrive anywhere.